Mohamed Khairie Issa
EVP, Head of US Oncology, Incyte.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 16, 2026Granted 7,857 shares of Incyte2
- Jul 16, 2026Sold 1,093 shares at $115.01 of Incyte2
- Jul 15, 2026Shares withheld for tax 1,099 shares at $115.09 of Incyte3
- Jan 7, 2026Sold 10,856 shares at $109.07 of Incyte4
- Jan 6, 2026Shares withheld for tax 8,264 shares at $106.66 of Incyte4
- Jul 15, 2025Granted 8,769 shares of Incyte5
- Jun 30, 2025Granted 27,812 shares of Incyte6
- Jan 6, 2025Granted 48,671 shares of Incyte7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARIncyte, EVP, Head of US Oncology
- 2
- 3SEC EDGARForm 4 filed Jul 16, 2026
- 4SEC EDGARForm 4 filed Jan 8, 2026
- 5SEC EDGARForm 4 filed Jul 17, 2025
- 6SEC EDGARForm 4 filed Jul 2, 2025
- 7SEC EDGARForm 4 filed Jan 8, 2025